AngioDynamics Inc (ANGO) stock
ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/306% below fair value
$12.42+0.35 (+2.90%)
Close on Nov 11, 2026Market cap $522.32MP/E –Yield –
AngioDynamics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
AngioDynamics's ebitda for the twelve months ending Aug 31, 2026 was -$14.07M. For fiscal 2026 it was -$16.97M. The highest annual figure on record is $38.82M in fiscal 2014.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | -$16.97M | – |
| FY2025 | May 31, 2025 | -$14.15M | – |
| FY2024 | May 31, 2024 | -$164.72M | – |
| FY2023 | May 31, 2023 | -$20.31M | -2413.0% |
| FY2022 | May 31, 2022 | $878.00K | – |
| FY2021 | May 31, 2021 | -$9.37M | – |
| FY2020 | May 31, 2020 | -$143.29M | -969.3% |
| FY2019 | May 31, 2019 | $16.48M | +83.3% |
| FY2018 | May 31, 2018 | $8.99M | -34.0% |
| FY2017 | May 31, 2017 | $13.64M | -53.2% |
| FY2016 | May 31, 2016 | $29.13M | +10.3% |
| FY2015 | May 31, 2015 | $26.41M | -32.0% |
| FY2014 | May 31, 2014 | $38.82M | +19.5% |
| FY2013 | May 31, 2013 | $32.47M | +244.2% |
| FY2012 | May 31, 2012 | $9.43M | -61.5% |
| FY2011 | May 31, 2011 | $24.48M | -26.6% |
| FY2010 | May 31, 2010 | $33.33M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -$1.80M | – |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -$4.60M | -10317.8% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -$7.36M | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -$308.00K | – |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$4.71M | – |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $45.00K | – |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$3.66M | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -$4.23M | – |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$6.31M | -115.1% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -$7.63M | – |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$192.37M | – |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -$6.44M | – |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $41.72M | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | -$13.28M | -1145.7% |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -$1.09M | -151.6% |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -$297.00K | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -$5.64M | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | $1.27M | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | $2.11M | -20.1% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$1.40M | -187.5% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$1.10M | -175.8% |
| Q4 FY2021CQ2 2021 | May 31, 2021 | -$15.06M | – |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $2.64M | +1194.6% |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $1.60M | -35.5% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | $1.46M | -66.8% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -$150.36M | -1657.3% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | $204.00K | -93.6% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $2.48M | -40.5% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | $4.38M | – |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $9.66M | – |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $3.19M | -69.8% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $4.17M | -40.6% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | -$530.00K | -108.9% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | -$14.53M | – |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $10.58M | -6.5% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $7.01M | -67.7% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $5.93M | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | -$29.12M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $11.31M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $21.72M | – |
See a number that looks wrong?